Report overview
Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.
This report aims to provide a comprehensive presentation of the global market for Atorvastatin Calcium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atorvastatin Calcium. This report contains market size and forecasts of Atorvastatin Calcium in global, including the following market information:
Global Atorvastatin Calcium Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Atorvastatin Calcium Market Sales, 2018-2023, 2024-2029, (MT)
Global top five Atorvastatin Calcium companies in 2022 (%)
The global Atorvastatin Calcium market was valued at US$ 225.3 million in 2022 and is projected to reach US$ 366.1 million by 2029, at a CAGR of 7.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The key players of global Atorvastatin Calcium include Pfizer, DSM Sinochem Pharmaceuticals, Ind-Swift, Cadila Pharmaceuticals, Morepen and Sun Pharmaceutical Industries. Pfizer is the leader of this industry with about 26% market shares. India and China are the main consumption bases, and India holds 35% consumption share, and China holds 18% consumption share. They occupy 54% of the global consumption in total.
We surveyed the Atorvastatin Calcium manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Atorvastatin Calcium Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Atorvastatin Calcium Market Segment Percentages, by Type, 2022 (%)
Chemical Synthesis
Biocatalysis
Global Atorvastatin Calcium Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Atorvastatin Calcium Market Segment Percentages, by Application, 2022 (%)
Tablet (Including Dispersible Tablet and General Tablet)
Capsule
Others
Global Atorvastatin Calcium Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (MT)
Global Atorvastatin Calcium Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Atorvastatin Calcium revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Atorvastatin Calcium revenues share in global market, 2022 (%)
Key companies Atorvastatin Calcium sales in global market, 2018-2023 (Estimated), (MT)
Key companies Atorvastatin Calcium sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
DSM Sinochem Pharmaceuticals
Ind-Swift
Cadila Pharmaceuticals
Morepen
Sun Pharmaceutical Industries
MSN Laboratories
Dr. Reddy's
Teva Pharmaceutical Industries
Apotex Pharmachem
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Atorvastatin Calcium, market overview.
Chapter 2: Global Atorvastatin Calcium market size in revenue and volume.
Chapter 3: Detailed analysis of Atorvastatin Calcium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Atorvastatin Calcium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Atorvastatin Calcium capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
